OBJECTIVE: To examine diploid-aneuploid mosaicism in human in vitro cultured blastocysts. DESIGN: A laboratory study on spare blastocysts from an IVF program. SETTING: University hospital laboratory. PATIENTS(S): Forty-three couples undergoing IVF or intracytoplasmic sperm injection. INTERVENTION(S): Ninety-one blastocysts were spread for fluorescence in situ hybridization using the HCl-Tween 20 method. A total of 6,664 nuclei were analyzed for aneuploidy using fluorescent DNA probes specific to chromosomes 2, 7, and 18. MAIN OUTCOME MEASURE(S): The proportion of aneuploid cells within each blastocyst. RESULTS(S): The incidence of diploid-aneuploid mosaicism among 91 blastocysts examined was 17.6%. All of the mosaic blastocysts were abnormal for only one of the three chromosomes tested, with the incidence of involvement of chromosomes 2, 7, and 18 being 3.3%, 8.8%, and 5.5%, respectively. The majority of the mosaic blastocysts had low proportions of aneuploid cells. Ten of the 16 (62.5%) affected blastocysts were of morphology compatible with implantation. CONCLUSION(S): A considerable proportion of human IVF blastocysts show a form of mosaicism that has been observed in fetal and placental tissues. This mosaicism often arises at the final stage of preimplantation development in vitro and is present in blastocysts of morphology compatible with implantation.
OBJECTIVE: To examine diploid-aneuploid mosaicism in human in vitro cultured blastocysts. DESIGN: A laboratory study on spare blastocysts from an IVF program. SETTING: University hospital laboratory. PATIENTS(S): Forty-three couples undergoing IVF or intracytoplasmic sperm injection. INTERVENTION(S): Ninety-one blastocysts were spread for fluorescence in situ hybridization using the HCl-Tween 20 method. A total of 6,664 nuclei were analyzed for aneuploidy using fluorescent DNA probes specific to chromosomes 2, 7, and 18. MAIN OUTCOME MEASURE(S): The proportion of aneuploid cells within each blastocyst. RESULTS(S): The incidence of diploid-aneuploid mosaicism among 91 blastocysts examined was 17.6%. All of the mosaic blastocysts were abnormal for only one of the three chromosomes tested, with the incidence of involvement of chromosomes 2, 7, and 18 being 3.3%, 8.8%, and 5.5%, respectively. The majority of the mosaic blastocysts had low proportions of aneuploid cells. Ten of the 16 (62.5%) affected blastocysts were of morphology compatible with implantation. CONCLUSION(S): A considerable proportion of humanIVF blastocysts show a form of mosaicism that has been observed in fetal and placental tissues. This mosaicism often arises at the final stage of preimplantation development in vitro and is present in blastocysts of morphology compatible with implantation.
Authors: Gianfranco Coppola; Basil Alexander; Dino Di Berardino; Elizabeth St John; Parvathi K Basrur; W Allan King Journal: Chromosome Res Date: 2007-05-10 Impact factor: 5.239
Authors: A V Eremeev; A V Svetlakov; A M Polstianoy; A N Bogomazova; E S Philonenko; Yu I Sheina; S L Kiselev; M A Lagarkova Journal: Dokl Biol Sci Date: 2009 May-Jun
Authors: Sandra Zamora; Ana Clavero; M Carmen Gonzalvo; Juan de Dios Luna Del Castillo; Jose Antonio Roldán-Nofuentes; Juan Mozas; Jose Antonio Castilla Journal: J Assist Reprod Genet Date: 2011-06-29 Impact factor: 3.412
Authors: D S Johnson; C Cinnioglu; R Ross; A Filby; G Gemelos; M Hill; A Ryan; D Smotrich; M Rabinowitz; M J Murray Journal: Mol Hum Reprod Date: 2010-07-19 Impact factor: 4.025
Authors: Cathérine Dupont; James Segars; Alan DeCherney; Barry D Bavister; D Randall Armant; Carol A Brenner Journal: Fertil Steril Date: 2009-09-03 Impact factor: 7.329
Authors: D S Johnson; G Gemelos; J Baner; A Ryan; C Cinnioglu; M Banjevic; R Ross; M Alper; B Barrett; J Frederick; D Potter; B Behr; M Rabinowitz Journal: Hum Reprod Date: 2010-01-24 Impact factor: 6.918
Authors: Stanislav A Vasilyev; Ekaterina N Tolmacheva; Oksana Yu Vasilyeva; Anton V Markov; Daria I Zhigalina; Lada A Zatula; Vasilissa A Lee; Ekaterina S Serdyukova; Elena A Sazhenova; Tatyana V Nikitina; Anna A Kashevarova; Igor N Lebedev Journal: J Assist Reprod Genet Date: 2020-11-10 Impact factor: 3.412